Literature DB >> 17210666

Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model.

Mariano E Fernandez-Miyakawa1, Derek J Fisher, Rachael Poon, Sameera Sayeed, Vicki Adams, Julian I Rood, Bruce A McClane, Francisco A Uzal.   

Abstract

Clostridium perfringens is capable of producing up to 15 toxins, including alpha-toxin (CPA), beta-toxin (CPB), epsilon-toxin (ETX), enterotoxin, beta2-toxin (CPB2), and perfringolysin O. Type B isolates, which must produce CPA, CPB, and ETX, are associated with animal illnesses characterized by sudden death or acute neurological signs, with or without intestinal damage. Type B pathogenesis in ruminants is poorly understood, with some animals showing lesions and clinical signs similar to those caused by either type C or type D infections. It is unknown whether host or environmental conditions are dominant for determining the outcome of type B disease or if disease outcomes are determined by variable characteristics of type B isolates. To help clarify this issue, 19 type B isolates were evaluated for toxin production during late-log-phase growth via quantitative Western blotting and by biological activity assays. Most type B isolates produced CPB levels similar to those produced by type C isolates in vitro and have the potential to produce genotype C-like disease. The lethality of type B isolate supernatants administered intravenously to mice was evaluated with or without prior trypsin treatment, and monoclonal antibody neutralization studies also were performed. Correlation analyses comparing toxin levels in type B supernatants versus lethality and neutralization studies both found that the main contributor to lethality without pretreatment with trypsin was CPB, whereas neutralization studies indicated that CPB and ETX were both important after trypsin pretreatment. At least part of the CPB produced by type B isolates remained active after trypsin treatment. However, the overall lethalities of most supernatants were lower after trypsin pretreatment. Also, there was a significant association between ETX, CPB2, and CPA production in vitro among type B isolates. However, our results suggest that both CPB and ETX are likely the most important contributors to the pathogenesis of C. perfringens type B infections in domestic animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210666      PMCID: PMC1828578          DOI: 10.1128/IAI.01672-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane.

Authors:  S Miyata; O Matsushita; J Minami; S Katayama; S Shimamoto; A Okabe
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

2.  Some properties of beta-toxin produced by Clostridium perfringens type C.

Authors:  J Sakurai; C L Duncan
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens.

Authors:  W Ba-Thein; M Lyristis; K Ohtani; I T Nisbet; H Hayashi; J I Rood; T Shimizu
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

4.  Response of ligated rabbit ileal loop to Clostridium perfringens type C strains and their toxic filtrates.

Authors:  T Yamagishi; Y Gyobu; K Sakamoto; S Ishisaka; K Saito; S Morinaga; S Katsuda; T Umei; K Konishi
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

5.  Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens.

Authors:  Anthony L Keyburn; Scott A Sheedy; Mark E Ford; Mark M Williamson; Milena M Awad; Julian I Rood; Robert J Moore
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

6.  Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.

Authors:  Derek J Fisher; Mariano E Fernandez-Miyakawa; Sameera Sayeed; Rachael Poon; Victoria Adams; Julian I Rood; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Occurrence of Clostridium perfringens beta2-toxin amongst animals, determined using genotyping and subtyping PCR assays.

Authors:  H S Garmory; N Chanter; N P French; D Bueschel; J G Songer; R W Titball
Journal:  Epidemiol Infect       Date:  2000-02       Impact factor: 2.451

8.  Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.

Authors:  Sameera Sayeed; M E Fernandez-Miyakawa; Derek J Fisher; Vicki Adams; Rachael Poon; Julian I Rood; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

9.  The presence of enterotoxigenic Clostridium perfringens strains in faeces of various animals.

Authors:  B Tschirdewahn; S Notermans; K Wernars; F Untermann
Journal:  Int J Food Microbiol       Date:  1991-11       Impact factor: 5.277

10.  The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens strain 13.

Authors:  Kaori Ohtani; Hameem I Kawsar; Kayo Okumura; Hideo Hayashi; Tohru Shimizu
Journal:  FEMS Microbiol Lett       Date:  2003-05-16       Impact factor: 2.742

View more
  27 in total

1.  Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.

Authors:  James R Theoret; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 2.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

3.  Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid.

Authors:  Kazuaki Miyamoto; Jihong Li; Sameera Sayeed; Shigeru Akimoto; Bruce A McClane
Journal:  J Bacteriol       Date:  2008-09-05       Impact factor: 3.490

Review 4.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

5.  Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

6.  Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.

Authors:  James R Theoret; Jihong Li; Mauricio A Navarro; Jorge P Garcia; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

7.  Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

8.  Organization of the cpe locus in CPE-positive clostridium perfringens type C and D isolates.

Authors:  Jihong Li; Kazuaki Miyamoto; Sameera Sayeed; Bruce A McClane
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon.

Authors:  Jorge E Vidal; Bruce A McClane; Juliann Saputo; Jaquelyn Parker; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

10.  Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.